Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Neural Therapeutics Inc (NURL)

0,015

0,00

(0,00%)

Geschlossen 26 Juni 10:00PM

Professionelle Tools für Privatanleger.

Premium

Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting

Toronto, Ontario--(Newsfile Corp. - June 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural...

Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Market

Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") is pleased to...

Neural Portfolio Company Hanf.com Expands German Retail Footprint with New Muhldorf am Inn Store and Four Refurbished Locations

Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF...

Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE

Toronto, Ontario--(Newsfile Corp. - May 1, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural...

Neural Therapeutics Announces Amendment to SIO Agreement, Concurrent Financing Terms, Shareholder Meeting Date and RSU Grant

Toronto, Ontario--(Newsfile Corp. - March 27, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF...

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - NURL

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - NURL Canada NewsWire VANCOUVER, BC, le 19...

Canadian Investment Regulatory Organization Trade Resumption - NURL

Canadian Investment Regulatory Organization Trade Resumption - NURL Canada NewsWire VANCOUVER, BC, Feb. 19, 2026 VANCOUVER, BC, Feb. 19...

Neural Therapeutics Announces CSE Application to Acquire Full Ownership of Hanf.com, Shareholder Meeting, SIO Agreement Amendment and Concurrent Financing

Toronto, Ontario--(Newsfile Corp. - February 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF...

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NURL

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NURL Canada NewsWire VANCOUVER, BC, le 19 févr...

Canadian Investment Regulatory Organization Trading Halt - NURL

Canadian Investment Regulatory Organization Trading Halt - NURL Canada NewsWire VANCOUVER, BC, Feb. 19, 2026 VANCOUVER, BC, Feb. 19, 2026...

Neural Portfolio Company Hanf.com Reports Strong Fiscal 2025 Results with 58% Revenue Growth and Positive Normalized Operating Income

Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF...

Neural's Portfolio Company Hanf.com Announces Sales Start of Ritual Herbs Nicotine and Tobacco Free Products

Toronto, Ontario--(Newsfile Corp. - January 27, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF...

CSE Bulletin: MOC Eligibility Update

Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below. Effective...

Neural's Portfolio Company Hanf.com Expands Retail Footprint to Northern Germany with Two New Stores in Bielefeld and Herford

Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF...

Neural Portfolio Company Hanf.com Reports Strong Fiscal 2024 Results with 65% Revenue Growth, Positive Cash Flow and Double-Digit Operating Margin; Continued Growth in 2025; First Half Revenues Up 31% Year-Over-Year

Toronto, Ontario--(Newsfile Corp. - October 8, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF...

Foren

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Neural Therapeutics

Shunlian E-Commerce (ID)

AI Music Distribution (ID)

ACP Holdings Acquisition

Ping An Biomedical

Franklin International M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

ADVFN

Haben Sie schon ein Konto? Anmelden

Haben Sie kein Konto? Registrieren

Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.